Filing Details
- Accession Number:
- 0000784199-21-000158
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-27 17:02:28
- Reporting Period:
- 2021-05-25
- Accepted Time:
- 2021-05-27 17:02:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1653206 | E John Davis | 1655 Roberts Blvd., Nw Kennesaw GA 30144 | Senior Vp, Global Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-05-25 | 5,402 | $29.67 | 79,236 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-25 | 880 | $29.70 | 78,356 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-25 | 6,457 | $29.65 | 71,899 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-05-25 | 5,402 | $26.24 | 84,638 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right To buy) | Disposition | 2021-05-25 | 5,402 | $26.24 | 5,402 | $26.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-02-19 | 2027-02-19 | No | 4 | M | Direct |
Footnotes
- Reflects weighted average price. Range of prices were between $29.47 to $30.14. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reflects weighted average price. Range of prices were between $29.47 to $30.04. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reflects weighted average price. Range of prices were between $29.44 to $30.135. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2021
Billionaire Hedge Funds
